Dr. Farah Garcia

Pathologist · Hôpital Pitié-Salpêtrière · France (FR) · Oncology

Tier 3STK-0071GoodOwner MSL JWJames Whitfield

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: NSCLC
Scientific interests: Elderly patients
Engagement preference: In person
Advisory boards: 0
Publications: 6
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 3: 1 per year (assumption)

Last engaged: 03 Aug 2026 (43 days ago)
Next planned contact: 03 Aug 2027
Last 6 months vs target: 100%
1 of 1 expected engagements

Insights from this stakeholder (0)

No insights captured from engagements with this stakeholder.

Engagement history (1)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
03 Aug 2026	Advisory board	In person	James Whitfield	Vantrexa	Sequencing after progressionComparator checkpoint monotherapy	0	—	Reviewed	ENG-0043

Timeline

03 Aug 2026
Advisory board
Sequencing after progression, Comparator checkpoint monotherapy

Related stakeholders (6)

Hôpital Pitié-Salpêtrière

Dr. Chloé Kimura
Thoracic medical oncologist
Tier 1
Dr. Sven Fischer
Thoracic medical oncologist
Tier 3
Dr. Ulrich Abbott
Pathologist
Tier 1
Dr. Hiroshi Castellano
Pathologist
Tier 3
Dr. Daniel Petit
Pathologist
Tier 1
Dr. Quentin Jensen
Academic nephrologist
Tier 2